Furthermore, gliomas with mutated isocitrate dehydrogenase (IDH1 and IDH2) showed elevated levels of oncometabolite D-2-hydroxyglutarate derived from glutamine via glutamate and α-KG conversion, demonstrating the importance of glutamine metabolism in the malignant progression of gliomas [22]. Here, IDH2 is linked to glioma.